Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone-modified natural frozen embryo transfer pilot study
ACTRN12624001144505Phase 4Not yet recruiting
- Sponsor
- The Royal Women's Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of progesterone in infertility (2 arms), sponsored by The Royal Women's Hospital. Primary endpoint: Presence of corpus luteum. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
progesterone
03
Conditions
infertility
Beyond the preview
Go deeper on ACTRN12624001144505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624001144505.